Refractory α/β-Hepatosplenic T-cell Lymphoma With Secondary CNS Dissemination and Severe Morbidity Related to Intrathecal Chemotherapy: A Case Report and Literature Review

Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e564-e567. doi: 10.1016/j.clml.2019.05.014. Epub 2019 May 29.

¹ Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; Medical School, University of Western Australia, Crawley, Western Australia, Australia; Linear Clinical Research, Nedlands, Western Australia, Australia.
² Medical School, University of Western Australia, Crawley, Western Australia, Australia; Department of Anatomical Pathology, Pathwest Laboratory Medicine WA, Nedlands, Western Australia, Australia.
³ Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia; Medical School, University of Western Australia, Crawley, Western Australia, Australia; Linear Clinical Research, Nedlands, Western Australia, Australia. Electronic address: chan.cheah@health.wa.gov.au.

No abstract available

Keywords: CNS relapse; Chemo-refractory; Hepatosplenic T-cell lymphoma; Intrathecal; Myelopathy.

Publication types